Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1998-8-12
|
pubmed:abstractText |
After successful marrow transplantation (BMT) iron overload remains an important cause of morbidity in Thalassemia. After BMT, patients have normal erythropoiesis capable of producing a hyperplastic response to phlebotomy so that this procedure can be contemplated as a method of mobilizing iron from overloaded tissues. Forty-one patients (mean age 16 +/- 2.9 years) with prolonged follow-up (range 2-7 years) after BMT were submitted to a moderate intensity phlebotomy program (6 ml/kg blood withdrawal at 14-day intervals) to reduce iron overload. Values are expressed as mean +/- SD or as median with a range (25th-75th percentile). Serum ferritin decreased from 2,587 (2,129-4,817) to 280 (132-920) micrograms/l (p < 0.0001), total transferrin increased from 2.34 +/- 0.37 to 2.9 +/- 0.66 g/l (p = 0.0001), transferrin saturation decreased from 90% +/- 14% to 39% +/- 34% (p < 0.0001). Liver iron concentration evaluated on liver biopsy specimens decreased from 20.8 (15.5-28.1) to 3 (0.9-14.6) mg/g dry weight (p < 0.0001). Alanine amino-transaminase from 5.2 +/- 3.4 to 1.6 +/- 1.2 (p < 0.0001) times the upper level of normality. The histological grading for chronic hepatitis (Histology Activity Index) decreased from 4.2 +/- 2.4 to 2.3 +/- 1.8 (p < 0.0001). Phlebotomy is a safe, efficient, and widely applicable method to decrease iron overload in "ex-thalassemic."
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0077-8923
|
pubmed:author |
pubmed-author:AngelucciEE,
pubmed-author:AnnibaliMM,
pubmed-author:BaroncianiDD,
pubmed-author:ErenNN,
pubmed-author:GalimbertiMM,
pubmed-author:GazievDD,
pubmed-author:GiardiniCC,
pubmed-author:LucarelliGG,
pubmed-author:MurettoPP,
pubmed-author:PolchiPP,
pubmed-author:RapsAA,
pubmed-author:RipaltiMM
|
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
850
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
288-93
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9668550-Adolescent,
pubmed-meshheading:9668550-Alanine Transaminase,
pubmed-meshheading:9668550-Bone Marrow Transplantation,
pubmed-meshheading:9668550-Female,
pubmed-meshheading:9668550-Ferritins,
pubmed-meshheading:9668550-Follow-Up Studies,
pubmed-meshheading:9668550-Humans,
pubmed-meshheading:9668550-Iron,
pubmed-meshheading:9668550-Liver,
pubmed-meshheading:9668550-Male,
pubmed-meshheading:9668550-Morbidity,
pubmed-meshheading:9668550-Phlebotomy,
pubmed-meshheading:9668550-Postoperative Complications,
pubmed-meshheading:9668550-Time Factors,
pubmed-meshheading:9668550-Transferrin,
pubmed-meshheading:9668550-beta-Thalassemia
|
pubmed:year |
1998
|
pubmed:articleTitle |
Treatment of iron overload in the "ex-thalassemic". Report from the phlebotomy program.
|
pubmed:affiliation |
Divisione di Ematologia di Muraglia, Azienda Ospedale di Pesaro, Italy. g.lucarelli@wnt.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|